Showing results (161-170 of 1,370) with videos related to
Sort By:
Pageof 137
Drug Development Research|October 9, 2010
Identification of novel cellular targets for therapeutic intervention against Ebola virus infection by siRNA screeningAndrey A Kolokoltsov, Mohammad F Saeed, Alexander N Freiberg, et al.Drug Development Research|September 9, 2014
Opportunities and challenges provided by cloud repositories for bioinformatics-enabled drug discoveryGratien Dalpé, Yann JolyDrug Development Research|September 9, 2014
Network measures for chemical library designNagamani Sukumar, Michael P Krein, Ganesh Prabhu, et al.Drug Development Research|August 28, 2014
Application of chemometric techniques in search of clinically applicable biomarkers of diseaseAlicja KotłowskaDrug Development Research|August 28, 2014
Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunitiesWenyong Yang, Linzhi Zou, Canhua Huang, et al.Drug Development Research|April 1, 2026
Novel Antioxidant Quinazoline Sulfonamide Derivatives Acting Through NQO1 Induction and Their Radiation-Based Biodistribution StudiesMostafa M Ghorab, Aiten M Soliman, Maureen Higgins, et al.Drug Development Research|May 21, 2026
TRIM26-Mediated CBX6 Ubiquitination Triggers NETosis to Drive Bladder Cancer Tumor Growth via the CNPY2/NF-κB Signaling PathwayXiaoJuan Xie, ZhenZhen Li, TongTong Qiu, et al.Drug Development Research|May 27, 2026
Lead Discovery via Scaffold Refinement: Structure-Guided Optimization of 1,2,4-Triazolo[1,5-a]Pyrimidines as Potent Dual EGFR/CDK-2 Inhibitors Targeting Colorectal CarcinomaRowida Nasr, Hesham Haffez, Mohamed S Nafie, et al.Drug Development Research|June 9, 2026
Entacapone Ameliorates MASLD by Inhibiting FTO Demethylase ActivitySunita Giri, Deepti Sharma, Vijay KumarDrug Development Research|April 10, 2026
Targeting the NLRP3 Inflammasome: Novel Inhibitors for Cardiovascular Diseases Management - A Narrative ReviewYomna S MomenPageof 137